Search

everythinglearnresearchcommunity

for

Search:↓

The study created a new method to test drugs that affect hormone processing in skin.

Women with PCOS have a higher risk of metabolic syndrome and need lifestyle changes and treatment.

Long-term testosterone therapy can cause hormone suppression, affect prostate and heart health, and alter physical characteristics, but does not increase prostate cancer risk and needs more research for full risk assessment.

MENT could be a better option than testosterone for male hormone therapy and birth control because it works well at lower doses and has fewer side effects on the prostate.

Male hormones affect COVID-19 severity and certain drugs targeting these hormones could help reduce the risk.

5α-reductase is essential for male sexual development and its inhibitors have potential in treating various conditions related to hormone action.

Male genital development is driven by androgen signaling and understanding it could help address congenital anomalies.

Understanding how androgens work is key for creating new treatments for prostate issues and hair/skin conditions.

Higher androgen levels do not cause baldness in men.

Men who start balding at age 20 may have a higher chance of getting aggressive prostate cancer.

Flutamide combined with an LHRH agonist effectively inhibits prostate growth, suggesting it could treat prostate cancer.

Men with low or no sperm count have lower salivary testosterone levels, and saliva testing can measure their testosterone well.

Mild thyroid issues don't affect the metabolism and hormones of women with PCOS.

The document suggests that targeting the hormone DHT could be a more effective treatment for prostate cancer than targeting testosterone.

Different animals have unique versions of the enzyme that changes testosterone into another hormone, which is important for creating effective treatments for prostate and hair loss conditions.

Antiandrogens have important biological effects, but more research is needed to understand them fully and compare their effectiveness and side effects to other treatments.

Androgens increase a growth factor in hair cells by creating reactive oxygen species, and antioxidants might help treat hair loss.

Hormones like testosterone and estrogen significantly affect hair growth and structure.

The workshop highlighted the genetic links and psychological impacts of hair loss and skin disorders.

FAI values above 6.4 may suggest high androgen levels and increased metabolic risks in Chinese women of reproductive age.

Five preservatives may disrupt hormone function and need more health and environmental risk assessment.

Many young women who donate blood have hormonal disorders like excess male hormones and PCOS.

Birth control pills combined with bicalutamide are more effective at reducing excessive hair growth in women with PCOS than birth control pills alone.

MK-386 and finasteride together effectively reduce DHT levels, potentially treating acne and male pattern baldness.

Menopausal women have higher androgen levels, which can cause symptoms like facial hair growth and low sexual desire.

The study found genetic differences related to hair development that may explain hair loss in a patient with Trichorhinophalangeal syndrome type I.

The document suggests treating individuals with nonclassic congenital adrenal hyperplasia who show symptoms, especially those related to excess male hormones.

Scientists have developed a new method to detect steroid abuse in athletes using cell-based tests, which could be the future of anti-doping methods.

The document concludes that proper diagnosis and a multidisciplinary approach are crucial for managing Congenital Adrenal Hyperplasia effectively.

Insulin resistance in women with PCOS can lead to serious health issues, but lifestyle changes and certain medications can help manage symptoms.